When was AJA Pharma founded?

AJA Pharma was founded in 2012.

Where is AJA Pharma located?

AJA Pharma is headquartered in Riyadh, Saudi Arabia.

How many employees does AJA Pharma have?

As of Jul 01, 2024, the latest employee count at AJA Pharma is 199.

Is AJA Pharma a funded company?

AJA Pharma is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does AJA Pharma rank among its competitors?

AJA Pharma ranks 231st amongst 878 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Nivagen Pharmaceuticals, which secured $5M in Aug, 2023.

Who are the top competitors of AJA Pharma?

AJA Pharma's top competitors include Akums, Rubicon and Jubilant Life Sciences. Among them, Nivagen Pharmaceuticals secured the most recent funding round in August, 2023.

AJA Pharma - 2026 Company Profile & Competitors

Company Details

AJA Pharma manufactures finished formulations such as tablets, capsules, liquid, semi-solids, and injectables. The products are of various therapeutic categories including cardiovascular, hematological, multivitamins, contraceptives, etc. They export their products to the Middle East. The company has manufacturing facilities certified by USFDA.

Website: ajapharma.com/en/
Social
Email ID: *****@ajapharma.com
Phone Number: +966 **********

Key Metrics

Founded Year

2012

Location

Riyadh, Saudi Arabia

Stage

Unfunded

Ranked

231^st among 878 active competitors

Employee Count

199 as on Jul 01, 2024

Similar Companies

Akums & 1091 more

View AJA Pharma's full profile

AJA Pharma has not raised any funding rounds yet.

AJA Pharma's employee count trend

AJA Pharma has 199 employees as of Jul 24. Here is AJA Pharma's employee count trend over the years:

Uncover AJA Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AJA Pharma include Akums, Rubicon and Jubilant Life Sciences. Here is the list of Top 10 competitors of AJA Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Akums 2004, Delhi (India), Public	CDMO focusing on spectrum of dosage forms and therapeutic segments	$70M	Quadria Capital & 5 others	60/100
2nd	Rubicon 2000, Mumbai (India), Public	CDMO offering drug development services through its proprietary drug delivery technologies	$4.62M	Kotak Private Equity Group, Kotak Mahindra Bank ... & 3 others	60/100
3rd	Jubilant Life Sciences 1978, Noida (India), Public	Company offering a suite of R&D and manufacturing services for small molecules and generics	-	Samena Capital, General Atlantic & 1 others	59/100
4th	Recipharm 1995, Jordbro (Sweden), Acquired	Contract services for pharmaceutical development and manufacturing	-	CPP Investments, Ampersand Capital	57/100
5th	Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired	Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution	$31M	Telegraph Hill Partners, BizCap & 1 others	56/100
6th	Nectar Lifesciences 1995, Chandigarh (India), Public	Manufacturer of cephalosporin APIs and generic formulations	$46.9M	Vedanta Capital, NSR Partners & 1 others	56/100
7th	Ipca Laboratories 1949, Mumbai (India), Public	Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and generic medications	-	ChrysCapital	56/100
8th	SAVA group 2003, Pune (India), Unfunded	Pharma company with a portfolio of domestic and export products, also offering CRAMS services	-	-	56/100
9th	Supriya Lifescience 2008, Mumbai (India), Public	Manufacturer of active pharmaceutical ingredients and finished dosage formulations for healthcare	-	-	54/100
10th	Halo Pharma 2006, Hanover (United States), Acquired	CDMO offering integrated drug development services	$25M	Noramco, SK Capital	53/100
231st	AJA Pharma 2012, Riyadh (Saudi Arabia), Unfunded	Manufacturer of tablets, capsules, liquid, semi-solids, and injectables	-	-	30/100